Search
for
Sort by
Research 571–600 of 1000+
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Chaos and antichaos in pathology
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Secondary cicatricial and other permanent alopecias
- ADVANCES IN PSORIASIS THERAPY
- Topical absorption and systemic toxicity
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Menopausal Acne – Challenges And Solutions
- Non-hemorrhage-related adverse effects of rivaroxaban
- Primary cutaneous follicle centre cell lymphoma of the scalp presenting with scarring alopecia
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Psychoactive drugs and skin
- Clinical Development of Topoisomerase-Interactive Drugs
- Hair loss
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability
- Fixed-Drug Eruption due to Dextromethorphan
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Adverse cutaneous effects of psychotropic medications
- The spectrum of nephrocutaneous diseases and associations
- Extensive Scalp Angioedema following High-Dose Diphenylcyclopropenone for Alopecia Areata
- Acne
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Diseases of the skin. Drug ill effects on the skin.
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review